sarpogrelate has been researched along with Scleroderma, Systemic in 1 studies
sarpogrelate: structure given in first source
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarpogrelate was considered to be a useful drug to improve skin ulcers and QOL in patients with SSc." | 5.38 | Effects of sarpogrelate hydrochloride on skin ulcers and quality of life in patients with systemic sclerosis. ( Furukawa, F; Ikeda, T; Kanazawa, N; Uede, K; Yoshimasu, T, 2012) |
| "Sarpogrelate was considered to be a useful drug to improve skin ulcers and QOL in patients with SSc." | 1.38 | Effects of sarpogrelate hydrochloride on skin ulcers and quality of life in patients with systemic sclerosis. ( Furukawa, F; Ikeda, T; Kanazawa, N; Uede, K; Yoshimasu, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshimasu, T | 1 |
| Ikeda, T | 1 |
| Uede, K | 1 |
| Kanazawa, N | 1 |
| Furukawa, F | 1 |
1 other study available for sarpogrelate and Scleroderma, Systemic
| Article | Year |
|---|---|
Effects of sarpogrelate hydrochloride on skin ulcers and quality of life in patients with systemic sclerosis.
Topics: Aged; Female; Humans; Male; Middle Aged; Quality of Life; Scleroderma, Diffuse; Scleroderma, Limited | 2012 |